NTRB
NTRB
NASDAQ · Pharmaceuticals

Nutriband Inc

$3.19
+0.05 (+1.59%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +981.8% upside
Low Target $26.32
Average Target $34.51
High Target $56.88
Current Price $3.19
Current
$3.19
Target
$34.51
$26.32 $34.51 avg $56.88
Scenario Analysis
Bear Case
$26.32
725.1%
Low target
Base Case
$34.51
+981.8%
Avg target
Bull Case
$56.88
+1,683.1%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$11.68
-72.7% from high
52-Week Low
$2.90
+10.0% from low
Target vs 52W High
$34.51
+195.5% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +18.3%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +22.2%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +27.7%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +42.3%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +217.3%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +170.3%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -33.2%